Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Cholestasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Large-scale testing (Phase 3)Study completedNCT03905330
What this trial is testing

Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

Who this might be right for
Progressive Familial Intrahepatic Cholestasis (PFIC)
Mirum Pharmaceuticals, Inc. 93
Post-approval studies (Phase 4)Ended earlyNCT02476994
What this trial is testing

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion

Who this might be right for
Essential Fatty Acid Deficiency (EFAD)
Baxter Healthcare Corporation 1
Testing effectiveness (Phase 2)UnknownNCT01739517
What this trial is testing

Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease

Who this might be right for
Short Bowel SyndromeCholestasis
Amarnath, Rathna, M.D. 20
Not applicableLooking for participantsNCT07569003
What this trial is testing

Prealbumin and IGF-1 Levels in Pediatric Chronic Cholestasis With Severe Malnutrition After Nutrition Therapy

Who this might be right for
Chronic CholestasisSevere MalnutritionPediatric Cholestasis
Universitas Indonesia 15
Testing effectiveness (Phase 2)Study completedNCT02047318
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS)

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc. 19
Not applicableWithdrawnNCT04807478
What this trial is testing

Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)

Who this might be right for
Parenteral Nutrition Associated Liver DiseaseEssential Fatty Acid DeficiencyNeurocognitive Deficit+2 more
Fresenius Kabi
Large-scale testing (Phase 3)Study completedNCT01194063
What this trial is testing

Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

Who this might be right for
Cholestasis
Kapiolani Medical Center For Women & Children 36
Testing effectiveness (Phase 2)Study completedNCT02057718
What this trial is testing

Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis

Who this might be right for
Progressive Familial Intrahepatic Cholestasis (PFIC)
Mirum Pharmaceuticals, Inc. 33
Large-scale testing (Phase 3)Study completedNCT03659916
What this trial is testing

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Who this might be right for
Progressive Familial Intrahepatic Cholestasis
Albireo, an Ipsen Company 116
Testing effectiveness (Phase 2)Study completedNCT03586674
What this trial is testing

Fibrates in Pediatric Cholestasis

Who this might be right for
Chronic Cholestasis
Hoda A. Atta 50